Literature DB >> 12072622

Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer.

C Ratto1, R Ricci, C Rossi, U Morelli, F M Vecchio, G B Doglietto.   

Abstract

PURPOSE: Mesorectal involvement is a common feature in rectal tumors. Neoplastic foci can be identified at pathologic examination of the mesorectum, but their incidence and prognostic significance remain to be defined.
METHODS: A series of 77 patients with extraperitoneal rectal cancer, resected with total mesorectal excision, entered the study. After fixation, the excised specimens were submitted to serial transverse sections and staining. Direct tumor infiltration, lymph node involvement, and neoplastic microfoci in the mesorectum were investigated. Patients with mesorectal foci were compared with those without deposits with regard to clinical and pathologic parameters; different patterns of foci (endovasal, endolymphatic, perineural, isolated) were also considered. Univariate and multivariate analyses were used to evaluate the impact on survival rate.
RESULTS: Neoplastic mesorectal involvement was found in 64 patients (83.1 percent). Direct tumor infiltration was detected in 66.2 percent, node involvement in 28.6 percent, microscopic foci in 44.2 percent of cases (endovasal in 11.7 percent, endolymphatic in 15.7 percent, perineural in 26 percent, isolated in 14.3 percent). In 7 cases (10.9 percent) microfoci alone (without any kind of other mesorectal involvement) were detected. Deposits were found in 18.8 percent of TNM Stage I tumors, in 46.9 percent of Stage II and in 59.3 percent of Stage III cancers. Similar incidence was found in patients treated with integrated therapies and surgery alone (43.3 vs. 44.7 percent, P = not significant). Poorer median (44.5 vs. 57 months, P = 0.04) five-year overall survival rate (43.4 vs. 63.3 percent, P = 0.016) and disease-free survival rate (43.3 vs. 57.7 percent, P = 0.048) were observed in patients with microscopic foci compared with those without deposits. Tumor configuration was found to be a independent prognostic factor for both overall and disease-free survival rates; furthermore, endolymphatic, perineural, and isolated foci significantly affected overall survival rate, while TNM staging affected disease-free survival rate.
CONCLUSIONS: The incidence of neoplastic foci in the mesorectum is high, even in early staged tumors and despite aggressive preoperative treatment. They seem to affect prognosis. Such features should, therefore, be considered when local excision of the tumor is planned. Presence of mesorectal foci should modify conventional staging of the rectal tumor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072622     DOI: 10.1007/s10350-004-6288-8

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  18 in total

1.  Ghost ileostomy after anterior resection for rectal cancer: a preliminary experience.

Authors:  Nino Gullà; Stefano Trastulli; Carlo Boselli; Roberto Cirocchi; Davide Cavaliere; Giorgio Maria Verdecchia; Umberto Morelli; Daniele Gentile; Emilio Eugeni; Daniela Caracappa; Chiara Listorti; Francesco Sciannameo; Giuseppe Noya
Journal:  Langenbecks Arch Surg       Date:  2011-04-09       Impact factor: 3.445

2.  Prognostic value of tumor shrinkage versus fragmentation following radiochemotherapy and surgery for rectal cancer.

Authors:  Monirath Hav; Louis Libbrecht; Karen Geboes; Liesbeth Ferdinande; Tom Boterberg; Wim Ceelen; Piet Pattyn; Claude Cuvelier
Journal:  Virchows Arch       Date:  2015-02-19       Impact factor: 4.064

3.  Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin.

Authors:  Gao-Ping Zhao; Zong-Guang Zhou; Wen-Zhang Lei; Yong-Yang Yu; Cun Wang; Zhao Wang; Xue-Lian Zheng; Rong Wang
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

4.  Lymph node negative colorectal cancers with isolated tumor deposits should be classified and treated as stage III.

Authors:  E J Th Belt; M F M van Stijn; H Bril; E S M de Lange-de Klerk; G A Meijer; S Meijer; H B A C Stockmann
Journal:  Ann Surg Oncol       Date:  2010-07-13       Impact factor: 5.344

Review 5.  Squamous cell cancer of the rectum.

Authors:  Tara Dyson; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

6.  Microscopic spread of low rectal cancer in regions of mesorectum: pathologic assessment with whole-mount sections.

Authors:  Zhao Wang; Zong-Guang Zhou; Cun Wang; Gao-Ping Zhao; You-Dai Chen; Hong-Kai Gao; Xue-Lian Zheng; Rong Wang; Dai-Yun Chen; Wei-Ping Liu
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

Review 7.  Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers.

Authors:  Jia-Yuan Peng; Zhong-Nan Li; Yu Wang
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

8.  Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemo-radiotherapy and surgery for rectal cancer.

Authors:  E Benzoni; D Intersimone; G Terrosu; V Bresadola; A Cojutti; F Cerato; C Avellini
Journal:  J Clin Pathol       Date:  2006-03-07       Impact factor: 3.411

9.  Prognostic Importance of Tumor Deposits in the Ipsilateral Axillary Region of Breast Cancer Patients.

Authors:  Merih Guray Durak; Tulay Canda; Betul Yilmaz; Nazli Sena Seker; Seda Eryigit Kokkoz; Zumre Arican Alicikus; Nesrin Akturk; Ilknur Bilkay Gorken; Hulya Ellidokuz; Ali Ibrahim Sevinc; Serdar Saydam; Sulen Sarioglu
Journal:  Pathol Oncol Res       Date:  2018-10-27       Impact factor: 3.201

10.  Prognostic significance and role in TNM stage of tumor deposits in esophageal cancer.

Authors:  Qi-Xin Shang; Yu-Shang Yang; Li-Yan Xu; En-Min Li; Wei-Peng Hu; Long-Qi Chen
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.